Kopin (KOPN) 10-Q 13 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 03, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-30
Entity File Number	0-19882
Entity Registrant Name	KOPIN CORPORATION
Entity Central Index Key	0000771266
Entity Tax Identification Number	04-2833935
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	125 North Drive
Entity Address, City or Town	Westborough
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01581-3335
City Area Code	(508)
Local Phone Number	870-5959
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	KOPN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		114,449,134

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
ASSETS
Cash and cash equivalents	$ 9,599,675	$ 8,258,878
Restricted cash	500,000
Marketable debt securities, at fair value	11,610,485	4,388,778
Accounts receivable, net of allowance of $1,025,000 in 2023 and $303,000 in 2022	7,118,214	6,537,891
Contract assets and unbilled receivables	5,882,340	4,068,364
Inventory	9,074,492	6,426,400
Prepaid taxes	104,671	105,495
Prepaid expenses and other current assets	1,478,375	1,074,867
Total current assets	45,368,252	30,860,673
Property, plant and equipment, net	1,794,832	1,831,641
Operating lease right-of-use assets	2,670,116	3,168,520
Other assets	169,132	170,132
Equity investments	4,603,014	7,721,206
Total assets	54,605,346	43,752,172
Current liabilities:
Accounts payable	7,187,025	5,438,980
Accrued payroll and expenses	1,717,584	2,879,139
Accrued warranty	2,161,000	1,966,000
Contract liabilities and billings in excess of revenues earned	668,046	930,500
Operating lease liabilities	762,521	786,928
Accrued post-retirement benefits	790,000	790,000
Other accrued liabilities	1,765,544	1,182,346
Customer deposits	559,503
Deferred tax liabilities	450,480	482,739
Total current liabilities	16,061,703	14,456,632
Noncurrent contract liabilities and asset retirement obligations	267,226	248,284
Operating lease liabilities, net of current portion	2,008,077	2,576,883
Accrued post-retirement benefits, net of current portion	507,496	1,110,000
Other long-term obligations, net of current portion	1,391,121	1,369,758
Total liabilities	20,235,623	19,761,557
Commitments and contingencies
Stockholders’ equity:
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
Common stock, par value $.01 per share: authorized, 150,000,000 shares; issued 114,415,269 shares in 2023 and 94,920,060 shares in 2022; outstanding 110,396,217 in 2023 and 92,883,524 in 2022, respectively	1,104,668	929,540
Additional paid-in capital	383,898,603	360,567,631
Treasury stock (70,635 shares in 2023 and 2022, at cost)	(103,127)	(103,127)
Accumulated other comprehensive income	1,135,641	1,176,068
Accumulated deficit	(351,666,062)	(338,406,815)
Total Kopin Corporation stockholders’ equity	34,369,723	24,163,297
Noncontrolling interest		(172,682)
Total Kopin Corporation stockholders’ equity	34,369,723	23,990,615
Total liabilities and stockholders’ equity	$ 54,605,346	$ 43,752,172

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 1,025,000	$ 303,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	3,000	3,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	114,415,269	94,920,060
Common stock, shares outstanding	110,396,217	92,883,524
Treasury stock, shares	70,635	70,635

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Revenues:
Total revenues	$ 10,598,497	$ 11,729,379	$ 31,816,544	$ 35,216,833
Expenses:
Cost of product revenues	5,437,953	7,987,154	17,759,117	23,676,283
Research and development	3,089,935	3,441,405	8,534,411	13,995,393
Selling, general and administration	4,798,598	4,320,117	15,912,848	13,112,133
Total expenses	13,326,486	15,748,676	42,206,376	50,783,809
Loss from operations	(2,727,989)	(4,019,297)	(10,389,832)	(15,566,976)
Other income (expense)
Interest income	299,506	21,663	623,971	41,195
Other income (expense), net	31,608	(3,225)	104,403	(7,952)
(Loss) gain on investments		(2,000,000)	(3,327,347)	2,700,000
Foreign currency transaction losses	(14,438)	(112,315)	(153,442)	(227,294)
Total other income (expense)	316,676	(2,093,877)	(2,752,415)	2,505,949
Loss before provision for income taxes and net loss attributable to noncontrolling interest	(2,411,313)	(6,113,174)	(13,142,247)	(13,061,027)
Tax provision	(39,000)	(36,000)	(117,000)	(108,000)
Net loss	(2,450,313)	(6,149,174)	(13,259,247)	(13,169,027)
Net loss attributable to the noncontrolling interest				280
Net loss attributable to Kopin Corporation	$ (2,450,313)	$ (6,149,174)	$ (13,259,247)	$ (13,168,747)
Net loss per share
Basic	$ (0.02)	$ (0.07)	$ (0.12)	$ (0.14)
Diluted	$ (0.02)	$ (0.07)	$ (0.12)	$ (0.14)
Weighted average number of common shares outstanding
Basic	110,360,814	93,516,231	108,436,146	91,317,288
Diluted	110,360,814	93,516,231	108,436,146	91,317,288
Net Product Revenues [Member]
Revenues:
Total revenues	$ 5,506,193	$ 8,254,686	$ 19,172,302	$ 23,765,872
Research And Development Revenues [Member]
Revenues:
Total revenues	4,956,386	3,374,873	11,737,062	11,089,015
Other Revenues [Member]
Revenues:
Total revenues	$ 135,918	$ 99,820	$ 907,180	$ 361,946

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Income Statement [Abstract]
Net loss	$ (2,450,313)	$ (6,149,174)	$ (13,259,247)	$ (13,169,027)
Other comprehensive loss, net of tax:
Foreign currency translation adjustments	(10,229)	(128,994)	31,955	(170,349)
Unrealized holding loss on marketable securities	(54,175)	(34,110)	(72,382)	(212,889)
Reclassification of holding losses in net loss				(522)
Other comprehensive loss, net of tax	(64,404)	(163,104)	(40,427)	(383,760)
Comprehensive loss	(2,514,717)	(6,312,278)	(13,299,674)	(13,552,787)
Comprehensive loss attributable to the noncontrolling interest				280
Comprehensive loss attributable to Kopin Corporation	$ (2,514,717)	$ (6,312,278)	$ (13,299,674)	$ (13,552,507)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 25, 2021	$ 900,691	$ 356,931,157	$ (366,110)	$ 1,414,351	$ (319,080,898)	$ 39,799,191	$ (172,334)	$ 39,626,857
Beginning balance, shares at Dec. 25, 2021	90,069,169
Vesting of restricted stock	$ 1,544	(1,544)
Vesting of restricted stock, shares	154,421
Stock-based compensation expense		656,073				656,073		656,073
Other comprehensive loss				(113,906)		(113,906)		(113,906)
Net loss					(1,372,641)	(1,372,641)	(23)	(1,372,664)
Restricted stock for tax withholding obligations			(95,613)			(95,613)		(95,613)
Ending balance, value at Mar. 26, 2022	$ 902,235	357,585,686	(461,723)	1,300,445	(320,453,539)	38,873,104	(172,357)	38,700,747
Ending balance, shares at Mar. 26, 2022	90,223,590
Beginning balance, value at Dec. 25, 2021	$ 900,691	356,931,157	(366,110)	1,414,351	(319,080,898)	39,799,191	(172,334)	39,626,857
Beginning balance, shares at Dec. 25, 2021	90,069,169
Other comprehensive loss								(383,760)
Net loss								(13,169,027)
Ending balance, value at Sep. 24, 2022	$ 926,270	360,673,851		1,030,591	(332,249,645)	30,381,067	(172,614)	30,208,453
Ending balance, shares at Sep. 24, 2022	92,627,059
Beginning balance, value at Mar. 26, 2022	$ 902,235	357,585,686	(461,723)	1,300,445	(320,453,539)	38,873,104	(172,357)	38,700,747
Beginning balance, shares at Mar. 26, 2022	90,223,590
Vesting of restricted stock	$ 500	(500)
Vesting of restricted stock, shares	50,000
Stock-based compensation expense		417,033				417,033		417,033
Other comprehensive loss				(106,750)		(106,750)		(106,750)
Issuance of common stock and pre-funded warrants, net of costs								41,400,000
Net loss					(5,646,932)	(5,646,932)	(257)	(5,647,189)
Sale of registered stock	$ 15,290	1,550,092	461,723			2,027,105		2,027,105
Sale of registered stock, Shares	1,529,047
Ending balance, value at Jun. 25, 2022	$ 918,025	359,552,311		1,193,695	(326,100,471)	35,563,560	(172,614)	35,390,946
Ending balance, shares at Jun. 25, 2022	91,802,637
Vesting of restricted stock	$ 1,495	(1,495)
Vesting of restricted stock, shares	149,422
Stock-based compensation expense		297,549				297,549		297,549
Other comprehensive loss				(163,104)		(163,104)		(163,104)
Net loss					(6,149,174)	(6,149,174)		(6,149,174)
Sale of registered stock	$ 6,750	825,486				832,236		832,236
Sale of registered stock, Shares	675,000
Ending balance, value at Sep. 24, 2022	$ 926,270	360,673,851		1,030,591	(332,249,645)	30,381,067	(172,614)	30,208,453
Ending balance, shares at Sep. 24, 2022	92,627,059
Beginning balance, value at Dec. 31, 2022	$ 929,540	360,567,631	(103,127)	1,176,068	(338,406,815)	24,163,297	(172,682)	23,990,615
Beginning balance, shares at Dec. 31, 2022	92,954,159
Vesting of restricted stock	$ 175	(175)
Vesting of restricted stock, shares	17,500
Stock-based compensation expense		194,190				194,190		194,190
Other comprehensive loss				6,227		6,227		6,227
Issuance of common stock and pre-funded warrants, net of costs	$ 170,000	21,165,000				21,335,000		21,335,000
Issuance of common stock and pre-funded warrants, net of costs, shares	17,000,000
Acquisition of noncontrolling interest		(172,682)				(172,682)	172,682
Net loss					(2,628,555)	(2,628,555)		(2,628,555)
Ending balance, value at Apr. 01, 2023	$ 1,099,715	381,753,964	(103,127)	1,182,295	(341,035,370)	42,897,477		42,897,477
Ending balance, shares at Apr. 01, 2023	109,971,659
Beginning balance, value at Dec. 31, 2022	$ 929,540	360,567,631	(103,127)	1,176,068	(338,406,815)	24,163,297	(172,682)	23,990,615
Beginning balance, shares at Dec. 31, 2022	92,954,159
Other comprehensive loss								(40,427)
Net loss								(13,259,247)
Ending balance, value at Sep. 30, 2023	$ 1,104,668	383,898,603	(103,127)	1,135,641	(351,666,062)	34,369,723		34,369,723
Ending balance, shares at Sep. 30, 2023	110,466,852
Beginning balance, value at Apr. 01, 2023	$ 1,099,715	381,753,964	(103,127)	1,182,295	(341,035,370)	42,897,477		42,897,477
Beginning balance, shares at Apr. 01, 2023	109,971,659
Vesting of restricted stock	$ 4,050	(4,050)
Vesting of restricted stock, shares	404,966
Stock-based compensation expense		1,191,257				1,191,257		1,191,257
Other comprehensive loss				17,750		17,750		17,750
Net loss					(8,180,379)	(8,180,379)		(8,180,379)
Ending balance, value at Jul. 01, 2023	$ 1,103,765	382,941,171	(103,127)	1,200,045	(349,215,749)	35,926,105		35,926,105
Ending balance, shares at Jul. 01, 2023	110,376,625
Vesting of restricted stock, shares	90,227
Other comprehensive loss								(64,404)
Net loss								(2,450,313)
Ending balance, value at Sep. 30, 2023	$ 1,104,668	$ 383,898,603	$ (103,127)	$ 1,135,641	$ (351,666,062)	$ 34,369,723		$ 34,369,723
Ending balance, shares at Sep. 30, 2023	110,466,852

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022
Cash flows from operating activities:
Net loss	$ (13,259,247)	$ (13,169,027)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	498,188	665,217
Accretion of premium or discount on marketable debt securities		128
Stock-based compensation	2,343,782	1,370,654
Foreign currency losses	27,478	339,186
Change in allowance for credit losses	726,413	4,772
Write-off of excess inventory	292,405	1,670,993
Investment impairment (unrealized gains on investments)	2,887,893	(2,700,000)
Loss on sale of property and plant	18,878	202,670
Income taxes	117,316	107,509
Changes in other non-cash items	194,890	1,451,478
Changes in assets and liabilities:
Accounts receivable	(2,137,460)	3,756,182
Contract assets and unbilled receivables	(1,651,437)	(2,302,972)
Inventory	(2,944,672)	(1,944,577)
Prepaid expenses, other current assets and other assets	(461,365)	(272,446)
Accounts payable and accrued expenses	1,799,444	(1,651,538)
Contract liabilities and billings in excess of revenue earned	(244,188)	(3,130,965)
Net cash used in operating activities	(11,791,682)	(15,602,736)
Cash flows from investing activities:
Other assets	14,656	23,802
Capital expenditures	(478,282)	(642,146)
Equity investment purchase		(499,998)
Proceeds from sale of marketable debt securities	10,374,593	1,000,000
Purchases of marketable debt securities	(17,624,779)	(4,000,042)
Net cash used in investing activities	(7,713,812)	(4,118,384)
Cash flows from financing activities:
Sale of treasury stock, net of costs		461,723
Issuance of common stock and pre-funded warrants, net of costs	21,335,000	2,397,618
Settlements of restricted stock for tax withholding obligations		(95,613)
Net cash provided by financing activities	21,335,000	2,763,728
Effect of exchange rate changes on cash	11,291	(205,125)
Net increase (decrease) in cash, cash equivalents, and restricted cash	1,840,797	(17,162,517)
Cash, cash equivalents and restricted cash:
Beginning of period	8,258,878	26,787,931
End of period	$ 10,099,675	$ 9,625,414

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Pay vs Performance Disclosure [Table]
Net Income (Loss) Attributable to Parent	$ (2,450,313)	$ (6,149,174)	$ (13,259,247)	$ (13,168,747)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The condensed consolidated financial statements of Kopin Corporation as of September 30, 2023 and for the nine month periods ended September 30, 2023 and September 24, 2022 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning. The condensed consolidated financial statements for the nine months ended September 30, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. The condensed consolidated financial statements for the nine months ended September 24, 2022 include the accounts of Kopin Corporation and its wholly owned subsidiaries. Net loss attributable to noncontrolling interest in the Company’s condensed consolidated statements of operations for the nine months ended September 24, 2022 represents the 20 The Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future. On January 27, 2023, the Company sold 17,000,000 6,000,000 0.99 21.4 On January 5, 2023, the Company entered into a Technology License Agreement and an Asset Purchase Agreement (the “LST Agreements”) with Lightning Silicon Technology, Inc. (“LST”). Pursuant to the LST Agreements, the Company issued a license to LST for certain technology associated with our Organic Light Emitting Technology, transferred in-process development contracts with two customers and accounts receivables that the Company had previously determined were not collectible. The technology license agreement provides for Kopin to transfer certain patents to LST if LST achieves certain milestones; however upon transfer, Kopin will receive a license to the technology. To the extent LST makes improvements to the technology licensed from Kopin, Kopin will receive a license for these improvements for certain markets. Kopin is not obligated to provide any additional funding support to LST. As consideration for the transaction, the Company received 18,000,000 20.0

ACCOUNTING STANDARDS

ACCOUNTING STANDARDS	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
ACCOUNTING STANDARDS	2. ACCOUNTING STANDARDS ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments became effective for smaller reporting companies for fiscal years beginning after December 15, 2022. The amendments in ASU 2016-13 are intended to provide more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. The Company adopted this standard on January 1, 2023 and there was not a material impact.

CASH AND CASH EQUIVALENTS, REST

CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE DEBT SECURITIES	9 Months Ended
	Sep. 30, 2023
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE DEBT SECURITIES	3. CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE DEBT SECURITIES The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents. Restricted cash of approximately $ 0.5 Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value.” The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations. The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three and nine months ended September 30, 2023 and September 24, 2022. Investments in available-for-sale marketable debt securities were as follows at September 30, 2023 and December 31, 2022: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Fair Value 2023 2022 2023 2022 2023 2022 U.S. government and agency backed securities $ 4,500,030 $ 2,500,006 $ (61,715 ) $ (102,276 ) $ 4,438,315 $ 2,397,730 Corporate debt and certificates of deposit 7,250,174 2,000,012 (78,004 ) (8,964 ) 7,172,170 1,991,048 Total $ 11,750,204 $ 4,500,018 $ (139,719 ) $ (111,240 ) $ 11,610,485 $ 4,388,778 The contractual maturity of the Company’s marketable debt securities was as follows at September 30, 2023: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five years Total U.S. government and agency backed securities $ 2,468,075 $ 1,970,240 $ 4,438,315 Corporate debt and certificates of deposit 3,724,927 3,447,243 7,172,170 Total $ 6,193,002 $ 5,417,483 $ 11,610,485

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	4. FAIR VALUE MEASUREMENTS Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, based on quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates or yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets. The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS Total Level 1 Level 2 Level 3 Fair Value Measurement at September 30, 2023 Using: Total Level 1 Level 2 Level 3 Cash and cash equivalents and restricted cash $ 10,099,675 $ 10,099,675 $ — $ — U.S. government securities 4,438,315 — 4,438,315 — Certificates of deposit 7,172,170 7,172,170 — — Equity investments 4,603,014 169,112 — 4,433,902 Financial instruments, owned, at fair value $ 26,313,174 $ 17,440,957 $ 4,438,315 $ 4,433,902 Total Level 1 Level 2 Level 3 Fair Value Measurement at December 31, 2022 Using: Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 8,258,878 $ 8,258,878 $ — $ — U.S. government securities 2,397,730 — 2,397,730 — Corporate debt 1,500,445 — 1,500,445 — Certificates of deposit 490,603 490,603 — — Equity investments 7,721,206 213,016 — 7,508,190 Financial instruments, owned, at fair value $ 20,368,862 $ 8,962,497 $ 3,898,175 $ 7,508,190 Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, LIABILITIES MEASURED ON RECURRING BASIS December 31, 2022 Net unrealized losses Foreign Purchases, issuances September 30, Equity investments $ 7,508,190 $ (3,327,347 ) $ (186,395 ) $ 439,454 $ 4,433,902 The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy. Marketable Debt Securities Corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate (“Three-month Libor”). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the Three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets. Equity Investments From 2017 through 2019, the Company made several equity investments in a customer. In the fourth quarter of 2019, the Company reviewed the financial condition and other factors of the customer and, as a result, recorded an impairment charge of $ 5.2 million to reduce its investment in the customer to zero as of December 28, 2019. In the first quarter of 2022, the customer raised additional equity capital and, based on an observable price change of the customer’s share prices and terms of the equity sale, the Company remeasured the fair market value of its investment and recorded a gain of $ 4.7 million. In the second quarter of 2022, the Company made an additional equity investment of $ 0.5 million. During the quarter ended July 1, 2023, the Company received common stock of the equity investment valued at approximately $ 0.4 million for the payment of royalties. During the three and nine months ended September 30, 2023, the Company also performed an impairment evaluation using an Option Pricing Method and as a result recorded impairment charges of approximately $ 0 3.1 million, respectively. As of September 30, 2023, the Company owned an approximate 2.9 % interest in this investment. On September 30, 2019, the Company entered into an Asset Purchase Agreement pursuant to which the Company sold and licensed certain assets of our SolosTM product line and WhisperTM Audio technology. As consideration for the transaction, the Company received a 20.0% equity stake in Solos Incorporation (“Solos Inc.”). The Company’s 20.0% equity stake will be maintained until Solos Inc. has raised a total of $ 7.5 million in equity financing. Based on the price paid for equity by the other 80.0% owners of Solos Inc. and other factors, the Company estimated the fair value of its equity holdings at $ 0.6 million and in 2019 recorded a $ 0.6 million gain on its investment for this equity transaction as the basis of assets transferred was zero. The investment was written down to $ 0.4 million as a result of an impairment analysis and write down performed in 2020 . During the three and nine months ended September 30, 2023, the Company recorded impairment charges of $ 0 0.2 million, respectively. During the three and nine months ended September 30, 2023, the Company recorded approximately $ 0.1 0.2

ACCOUNTS RECEIVABLE, NET

ACCOUNTS RECEIVABLE, NET	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
ACCOUNTS RECEIVABLE, NET	5. ACCOUNTS RECEIVABLE, NET Accounts receivable consisted of the following: SCHEDULE OF ACCOUNTS RECEIVABLE September 30, 2023 December 31, 2022 Accounts receivable $ 8,143,214 $ 6,840,891 Less — allowance for credit losses (1,025,000 ) (303,000 ) Total $ 7,118,214 $ 6,537,891 Changes to the allowance for credit losses for the nine months ended September 30, 2023 were as follows: SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES Balance, December 31, 2022 $ 303,000 Additions 798,000 Write-offs (76,000 ) Balance, September 30, 2023 $ 1,025,000

INVENTORY

INVENTORY	9 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
INVENTORY	6. INVENTORY Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 30, 2023 and December 31, 2022: SCHEDULE OF INVENTORY September 30, 2023 December 31, 2022 Raw materials $ 5,522,913 $ 4,285,757 Work-in-process 2,527,748 1,735,454 Finished goods 1,023,831 405,189 Total $ 9,074,492 $ 6,426,400

NET LOSS PER SHARE

NET LOSS PER SHARE	9 Months Ended
	Sep. 30, 2023
Net loss per share
NET LOSS PER SHARE	7. NET LOSS PER SHARE Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of unvested restricted stock. The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Non-vested restricted common stock 3,948,417 2,480,299 3,948,417 2,480,299

STOCKHOLDERS_ EQUITY AND STOCK-

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	8. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Registered sale of equity securities On January 27, 2023, the Company sold 17,000,000 6,000,000 0.99 22.9 1.5 0.01 During the three months ended June 25, 2022, the Company sold 1.5 0.2 2.1 1.26 0.1 50 41.4 Non-Vested Restricted Common Stock The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested restricted common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting performance criteria. For non-vested restricted common stock awards that solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards that require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed. The Company granted 3,296,051 996,500 1,416,294 3,296,051 1,879,757 3,296,051 Restricted stock activity for the nine months ended September 30, 2023 was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Weighted Average Shares Grant Fair Value Balance, December 31, 2022 1,965,901 $ 2.22 Granted 3,296,051 1.59 Forfeited (800,842 ) 2.83 Vested (512,693 ) 1.55 Balance, September 30, 2023 3,948,417 $ 1.66 Stock-Based Compensation The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 30, 2023 and September 24, 2022 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Cost of product revenues $ 311,455 $ 41,373 $ 764,996 $ 119,754 Research and development 214,320 111,928 553,488 367,654 Selling, general and administrative 432,560 144,247 1,025,298 883,246 Total $ 958,335 $ 297,548 $ 2,343,782 $ 1,370,654 Unrecognized compensation expense for non-vested restricted common stock as of September 30, 2023 totaled $ 6.6 million and is expected to be recognized over a weighted average period of approximately three years .

ACCRUED WARRANTY

ACCRUED WARRANTY	9 Months Ended
	Sep. 30, 2023
Guarantees and Product Warranties [Abstract]
ACCRUED WARRANTY	9. ACCRUED WARRANTY The Company typically warrants its products against defects for 12 to 18 months SCHEDULE OF ACCRUED WARRANTY Balance, December 31, 2022 $ 1,966,000 Additions 676,000 Claims (481,000 ) Balance, September 30, 2023 $ 2,161,000 Extended Warranties Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months standard 12 to 18 month warranty 0.1

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES The Company recorded a provision for income taxes of less than $ 0.1 0.1 135.5 92.9

CONTRACT ASSETS AND LIABILITIES

CONTRACT ASSETS AND LIABILITIES	9 Months Ended
	Sep. 30, 2023
Contract Assets And Liabilities
CONTRACT ASSETS AND LIABILITIES	11. CONTRACT ASSETS AND LIABILITIES Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized from customer arrangements, including licensing, exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under other assets in its condensed consolidated balance sheets. Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue. Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY September 30, 2023 December 31, 2022 $ Change % Change Contract assets —current $ 5,882,340 $ 4,068,364 $ 1,813,976 45 % Contract liabilities—current (668,046 ) (930,500 ) 262,454 (28 )% Contract liabilities—noncurrent (23,431 ) (6,190 ) (17,241 ) 279 % Net contract assets $ 5,190,863 $ 3,131,674 $ 2,059,189 66 % The $ 2.0 In the three and nine months ended September 30, 2023, the Company recognized revenue of less than $ 0.1 0.7 0.5 3.6 The Company did not recognize impairment losses on our contract assets in the three or nine months ended September 30, 2023 or September 24, 2022. Performance Obligations The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION Three months ended Three months ended Nine months ended Nine months ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Point in time 24 % 29 % 27 % 23 % Over time 76 % 71 % 73 % 77 % Performance obligation percentage Remaining performance obligations represent the transaction price of orders for which work has not been performed and excludes unexercised contract options, potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity (“IDIQ”)) and purchase orders that we have historically allowed customers to cancel or reschedule. As of September 30, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $ 14.2

LEASES

LEASES	9 Months Ended
	Sep. 30, 2023
Leases
LEASES	12. LEASES The Company enters into operating leases primarily for: real estate, including for manufacturing, engineering, research, administration and sales facilities, and information technology (“IT”) equipment. At September 30, 2023 and December 31, 2022, the Company did not have any finance leases. Approximately all of our future lease commitments, and related lease liability, relate to the Company’s real estate leases. Some of the Company’s leases include options to extend or terminate the lease. The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Operating lease cost $ 216,119 $ 242,833 $ 648,545 $ 742,697 At September 30, 2023, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2023 (excluding the nine months ended September 30, 2023) $ 234,233 2024 894,227 2025 637,893 2026 604,000 2027 604,000 Thereafter 201,333 Total future lease payments 3,175,686 Less imputed interest (405,088 ) Total $ 2,770,598 The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheets at September 30, 2023 were as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS September 30, 2023 Operating lease liabilities - current $ 762,521 Operating lease liabilities - noncurrent 2,008,077 Total lease liabilities $ 2,770,598 Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Nine months ended September 30, 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 741,757 Other information related to leases was as follows: September 30, 2023 Weighted Average Discount Rate - Operating Leases 6.06 % Weighted Average Remaining Lease Term - Operating Leases (in years) 4.11

SEGMENTS AND DISAGGREGATION OF

SEGMENTS AND DISAGGREGATION OF REVENUE	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
SEGMENTS AND DISAGGREGATION OF REVENUE	13. SEGMENTS AND DISAGGREGATION OF REVENUE We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine if any changes have occurred that would affect our reportable segments. We report under one segment, as our Chief Executive Officer, who is our chief operating decision maker (“CODM”), reviews results on a total company basis. Total long-lived assets by country at September 30, 2023 and December 31, 2022 were as follows: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) September 30, 2023 December 31, 2022 United States $ 4,194 $ 4,604 United Kingdom 271 396 Total $ 4,465 $ 5,000 We disaggregate our revenue from contracts with customers by geographic location and by display application, as we believe it best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. During the three and nine months ended September 30, 2023 and September 24, 2022, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE Three months ended Three months ended Nine months ended Nine months ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 (In thousands, except percentages) Revenue % of Total Revenue % of Total Revenue % of Total Revenue % of Total United States $ 9,879 94 % $ 9,360 80 % $ 27,788 88 % $ 28,695 82 % Other Americas — — 4 — 5 — 4 - Total Americas 9,879 94 9,364 80 27,793 88 28,699 82 Asia – Pacific 363 3 2,039 17 2,956 9 5,747 16 Europe 356 3 326 3 1,068 3 771 2 Total Revenues $ 10,598 100 % $ 11,729 100 % $ 31,817 100 % $ 35,217 100 % During the three and nine months ended September 30, 2023 and September 24, 2022, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three months ended Three months ended Nine months ended Nine months ended (In thousands) September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Defense $ 4,996 $ 5,851 $ 16,482 $ 17,695 Industrial 310 1,727 2,118 4,889 Consumer 200 676 573 1,182 R&D 4,956 3,375 11,737 11,089 License and royalties 136 100 907 362 Total Revenues $ 10,598 $ 11,729 $ 31,817 $ 35,217

LITIGATION

LITIGATION	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	14. LITIGATION The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations, and proceedings are inherently uncertain. It is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period. BlueRadios, Inc. v. Kopin Corporation, Civil Action No. 16-02052-JLK (D. Col.): On August 12, 2016, BlueRadios, Inc. (“BlueRadios”) filed a complaint in the U.S. District Court for the District of Colorado, alleging that the Company breached a contract between it and BlueRadios concerning an alleged joint venture between the Company and BlueRadios to design, develop and commercialize micro-display products with embedded wireless technology referred to as “Golden-i” breached the covenant of good faith and fair dealing associated with that contract, breached its fiduciary duty to BlueRadios, and misappropriated trade secrets owned by BlueRadios in violation of Colorado law (C.R.S. § 7-74-104(4)) and the Defend Trade Secrets Act (18 U.S.C. § 1836(b)(1)). BlueRadios further alleges that the Company was unjustly enriched by its alleged misconduct, BlueRadios is entitled to an accounting to determine the amount of profits obtained by the Company as a result of its alleged misconduct, and the inventorship on at least ten patents or patent applications owned by the Company need to be corrected to list BlueRadios’ employees as inventors and thereby list BlueRadios as co-assignees of the patents. BlueRadios seeks monetary, declaratory, and injunctive relief, including for alleged non-payment of engineering retainer fees. On October 11, 2016, the Company filed its Answer and Affirmative Defenses. The parties completed expert depositions on November 15, 2019. On December 2, 2019, the Company filed a Motion for Partial Summary Judgment requesting the court dismiss counts 2-7 in their entirety and counts 1 and 8 in part. BlueRadios also filed a Motion for Partial Summary Judgment alleging that it is the co-owner of U.S. Patent No. 8,909,296. Responses to the Motions for Partial Summary Judgment were filed on January 15, 2020, and replies were filed on February 19, 2020. On September 25, 2020, the court denied BlueRadios’ Motion for Partial Summary Judgment. On August 3, 2022, the court granted the Company’s Motion for Partial Summary Judgment by dismissing counts 3, 6, 7, punitive damages under count 2, and count 8 as it relates to patent applications, and denying the motion as it relates to counts 1, 4, and 5, and the remainder of counts 2 and 8. Additional factual and expert discovery ordered by the court has been completed. A trial date has been set by the court for January 22 – February 5, 2024. The Company has not concluded a loss from this matter is probable; therefore, we have not recorded an accrual for litigation or claims related to this matter for the period ended September 30, 2023. The Company will continue to evaluate information as it becomes known and will record an estimate for losses at the time or times when it is both probable that a loss has been incurred and the amount of the loss is reasonably estimable.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	15. RELATED PARTY TRANSACTIONS The Company may from time to time enter into agreements with stockholders, affiliates and other companies engaged in certain aspects of the display, electronics, optical and software industries as part of our business strategy. In addition, the wearable computing product market is relatively new and there may be other technologies the Company needs to purchase from affiliates to enhance its product offering. During the three and nine months ended September 30, 2023 and September 24, 2022, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three Months Ended September 30, 2023 September 24, 2022 Sales Purchases Sales Purchases RealWear, Inc. $ 135,918 $ — $ 108,725 $ — HMDmd, Inc. 349,420 — 329,100 — Lightning Silicon Technology, Inc. — 208,933 — — $ 485,338 $ 208,933 $ 437,825 $ — Nine Months Ended September 30, 2023 September 24, 2022 Sales Purchases Sales Purchases RealWear, Inc. $ 905,564 $ — $ 827,746 $ — HMDmd, Inc. 852,175 — 392,025 — Lightning Silicon Technology, Inc. — 416,988 — — $ 1,757,739 $ 416,988 $ 1,219,771 $ — At September 30, 2023 and December 31, 2022, the Company had the following receivables from and payables to related parties: September 30, 2023 December 31, 2022 Receivables Payables Receivables Payables RealWear, Inc. $ 135,918 $ — $ 171,518 $ — HMDmd, Inc. 92,752 — 151,340 — Solos Technology — — 2,248 — Lightning Silicon Technology, Inc. 12,962 154,933 — — $ 241,632 $ 154,933 $ 325,106 $ —

CASH AND CASH EQUIVALENTS, RE_2

CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE DEBT SECURITIES (Tables)	9 Months Ended
	Sep. 30, 2023
Cash and Cash Equivalents [Abstract]
SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES	Investments in available-for-sale marketable debt securities were as follows at September 30, 2023 and December 31, 2022: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Fair Value 2023 2022 2023 2022 2023 2022 U.S. government and agency backed securities $ 4,500,030 $ 2,500,006 $ (61,715 ) $ (102,276 ) $ 4,438,315 $ 2,397,730 Corporate debt and certificates of deposit 7,250,174 2,000,012 (78,004 ) (8,964 ) 7,172,170 1,991,048 Total $ 11,750,204 $ 4,500,018 $ (139,719 ) $ (111,240 ) $ 11,610,485 $ 4,388,778
SCHEDULE OF MARKETABLE DEBT SECURITIES	The contractual maturity of the Company’s marketable debt securities was as follows at September 30, 2023: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five years Total U.S. government and agency backed securities $ 2,468,075 $ 1,970,240 $ 4,438,315 Corporate debt and certificates of deposit 3,724,927 3,447,243 7,172,170 Total $ 6,193,002 $ 5,417,483 $ 11,610,485

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS	The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS Total Level 1 Level 2 Level 3 Fair Value Measurement at September 30, 2023 Using: Total Level 1 Level 2 Level 3 Cash and cash equivalents and restricted cash $ 10,099,675 $ 10,099,675 $ — $ — U.S. government securities 4,438,315 — 4,438,315 — Certificates of deposit 7,172,170 7,172,170 — — Equity investments 4,603,014 169,112 — 4,433,902 Financial instruments, owned, at fair value $ 26,313,174 $ 17,440,957 $ 4,438,315 $ 4,433,902 Total Level 1 Level 2 Level 3 Fair Value Measurement at December 31, 2022 Using: Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 8,258,878 $ 8,258,878 $ — $ — U.S. government securities 2,397,730 — 2,397,730 — Corporate debt 1,500,445 — 1,500,445 — Certificates of deposit 490,603 490,603 — — Equity investments 7,721,206 213,016 — 7,508,190 Financial instruments, owned, at fair value $ 20,368,862 $ 8,962,497 $ 3,898,175 $ 7,508,190
SCHEDULE OF FAIR VALUE, LIABILITIES MEASURED ON RECURRING BASIS	Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, LIABILITIES MEASURED ON RECURRING BASIS December 31, 2022 Net unrealized losses Foreign Purchases, issuances September 30, Equity investments $ 7,508,190 $ (3,327,347 ) $ (186,395 ) $ 439,454 $ 4,433,902

ACCOUNTS RECEIVABLE, NET (Table

ACCOUNTS RECEIVABLE, NET (Tables)	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
SCHEDULE OF ACCOUNTS RECEIVABLE	Accounts receivable consisted of the following: SCHEDULE OF ACCOUNTS RECEIVABLE September 30, 2023 December 31, 2022 Accounts receivable $ 8,143,214 $ 6,840,891 Less — allowance for credit losses (1,025,000 ) (303,000 ) Total $ 7,118,214 $ 6,537,891
SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES	Changes to the allowance for credit losses for the nine months ended September 30, 2023 were as follows: SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES Balance, December 31, 2022 $ 303,000 Additions 798,000 Write-offs (76,000 ) Balance, September 30, 2023 $ 1,025,000

INVENTORY (Tables)

INVENTORY (Tables)	9 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORY	Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 30, 2023 and December 31, 2022: SCHEDULE OF INVENTORY September 30, 2023 December 31, 2022 Raw materials $ 5,522,913 $ 4,285,757 Work-in-process 2,527,748 1,735,454 Finished goods 1,023,831 405,189 Total $ 9,074,492 $ 6,426,400

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2023
Net loss per share
SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK	The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Non-vested restricted common stock 3,948,417 2,480,299 3,948,417 2,480,299

STOCKHOLDERS_ EQUITY AND STOC_2

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY	Restricted stock activity for the nine months ended September 30, 2023 was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Weighted Average Shares Grant Fair Value Balance, December 31, 2022 1,965,901 $ 2.22 Granted 3,296,051 1.59 Forfeited (800,842 ) 2.83 Vested (512,693 ) 1.55 Balance, September 30, 2023 3,948,417 $ 1.66
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 30, 2023 and September 24, 2022 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Cost of product revenues $ 311,455 $ 41,373 $ 764,996 $ 119,754 Research and development 214,320 111,928 553,488 367,654 Selling, general and administrative 432,560 144,247 1,025,298 883,246 Total $ 958,335 $ 297,548 $ 2,343,782 $ 1,370,654

ACCRUED WARRANTY (Tables)

ACCRUED WARRANTY (Tables)	9 Months Ended
	Sep. 30, 2023
Guarantees and Product Warranties [Abstract]
SCHEDULE OF ACCRUED WARRANTY	SCHEDULE OF ACCRUED WARRANTY Balance, December 31, 2022 $ 1,966,000 Additions 676,000 Claims (481,000 ) Balance, September 30, 2023 $ 2,161,000

CONTRACT ASSETS AND LIABILITI_2

CONTRACT ASSETS AND LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2023
Contract Assets And Liabilities
SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY	Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY September 30, 2023 December 31, 2022 $ Change % Change Contract assets —current $ 5,882,340 $ 4,068,364 $ 1,813,976 45 % Contract liabilities—current (668,046 ) (930,500 ) 262,454 (28 )% Contract liabilities—noncurrent (23,431 ) (6,190 ) (17,241 ) 279 % Net contract assets $ 5,190,863 $ 3,131,674 $ 2,059,189 66 %
SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION	The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION Three months ended Three months ended Nine months ended Nine months ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Point in time 24 % 29 % 27 % 23 % Over time 76 % 71 % 73 % 77 % Performance obligation percentage

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2023
Leases
SCHEDULE OF LEASE EXPENSE	The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Operating lease cost $ 216,119 $ 242,833 $ 648,545 $ 742,697
SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE	At September 30, 2023, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2023 (excluding the nine months ended September 30, 2023) $ 234,233 2024 894,227 2025 637,893 2026 604,000 2027 604,000 Thereafter 201,333 Total future lease payments 3,175,686 Less imputed interest (405,088 ) Total $ 2,770,598
SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS	The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheets at September 30, 2023 were as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS September 30, 2023 Operating lease liabilities - current $ 762,521 Operating lease liabilities - noncurrent 2,008,077 Total lease liabilities $ 2,770,598
SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES	Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Nine months ended September 30, 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 741,757 Other information related to leases was as follows: September 30, 2023 Weighted Average Discount Rate - Operating Leases 6.06 % Weighted Average Remaining Lease Term - Operating Leases (in years) 4.11

SEGMENTS AND DISAGGREGATION O_2

SEGMENTS AND DISAGGREGATION OF REVENUE (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS	Total long-lived assets by country at September 30, 2023 and December 31, 2022 were as follows: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) September 30, 2023 December 31, 2022 United States $ 4,194 $ 4,604 United Kingdom 271 396 Total $ 4,465 $ 5,000
SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE	During the three and nine months ended September 30, 2023 and September 24, 2022, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE Three months ended Three months ended Nine months ended Nine months ended September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 (In thousands, except percentages) Revenue % of Total Revenue % of Total Revenue % of Total Revenue % of Total United States $ 9,879 94 % $ 9,360 80 % $ 27,788 88 % $ 28,695 82 % Other Americas — — 4 — 5 — 4 - Total Americas 9,879 94 9,364 80 27,793 88 28,699 82 Asia – Pacific 363 3 2,039 17 2,956 9 5,747 16 Europe 356 3 326 3 1,068 3 771 2 Total Revenues $ 10,598 100 % $ 11,729 100 % $ 31,817 100 % $ 35,217 100 %
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT	During the three and nine months ended September 30, 2023 and September 24, 2022, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three months ended Three months ended Nine months ended Nine months ended (In thousands) September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Defense $ 4,996 $ 5,851 $ 16,482 $ 17,695 Industrial 310 1,727 2,118 4,889 Consumer 200 676 573 1,182 R&D 4,956 3,375 11,737 11,089 License and royalties 136 100 907 362 Total Revenues $ 10,598 $ 11,729 $ 31,817 $ 35,217

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES	During the three and nine months ended September 30, 2023 and September 24, 2022, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three Months Ended September 30, 2023 September 24, 2022 Sales Purchases Sales Purchases RealWear, Inc. $ 135,918 $ — $ 108,725 $ — HMDmd, Inc. 349,420 — 329,100 — Lightning Silicon Technology, Inc. — 208,933 — — $ 485,338 $ 208,933 $ 437,825 $ — Nine Months Ended September 30, 2023 September 24, 2022 Sales Purchases Sales Purchases RealWear, Inc. $ 905,564 $ — $ 827,746 $ — HMDmd, Inc. 852,175 — 392,025 — Lightning Silicon Technology, Inc. — 416,988 — — $ 1,757,739 $ 416,988 $ 1,219,771 $ — At September 30, 2023 and December 31, 2022, the Company had the following receivables from and payables to related parties: September 30, 2023 December 31, 2022 Receivables Payables Receivables Payables RealWear, Inc. $ 135,918 $ — $ 171,518 $ — HMDmd, Inc. 92,752 — 151,340 — Solos Technology — — 2,248 — Lightning Silicon Technology, Inc. 12,962 154,933 — — $ 241,632 $ 154,933 $ 325,106 $ —

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Narrative) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended
	Jan. 27, 2023	Jan. 05, 2023	Jun. 25, 2022	Sep. 24, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of registered common stock sold	17,000,000
LST Agreement [Member] | Lightning Silicon Technology Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues		18,000,000
Prefunded Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of registered common stock sold			100,000
Pre-funded warrants issued to purchase common stock	6,000,000
Offering price per share	$ 0.99
Proceeds from issuance of warrants	$ 21.4
EMDT [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Equity ownership percentage				20%
Lightning Silicon Technology Inc [Member] | LST Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Equity ownership percentage		20%

SCHEDULE OF AVAILABLE-FOR-SALE

SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Amortized Cost	$ 11,750,204	$ 4,500,018
Unrealized (Losses) Gains	(139,719)	(111,240)
Fair Value	11,610,485	4,388,778
US Government Corporations and Agencies Securities [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Amortized Cost	4,500,030	2,500,006
Unrealized (Losses) Gains	(61,715)	(102,276)
Fair Value	4,438,315	2,397,730
Corporate Debt and Certificates of Deposit [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Amortized Cost	7,250,174	2,000,012
Unrealized (Losses) Gains	(78,004)	(8,964)
Fair Value	$ 7,172,170	$ 1,991,048

SCHEDULE OF MARKETABLE DEBT SEC

SCHEDULE OF MARKETABLE DEBT SECURITIES (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Less than One year	$ 6,193,002
One to Five Years	5,417,483
Total	11,610,485	$ 4,388,778
US Government Corporations and Agencies Securities [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Less than One year	2,468,075
One to Five Years	1,970,240
Total	4,438,315	$ 2,397,730
Corporate Debt And Certificate Of Deposit [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Less than One year	3,724,927
One to Five Years	3,447,243
Total	$ 7,172,170

CASH AND CASH EQUIVALENTS, RE_3

CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE DEBT SECURITIES (Details Narrative) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Restricted cash	$ 500,000

SCHEDULE OF FAIR VALUE MEASUREM

SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	$ 26,313,174	$ 20,368,862
Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	17,440,957	8,962,497
Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,438,315	3,898,175
Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,433,902	7,508,190
Cash and Cash Equivalents [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	10,099,675	8,258,878
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	10,099,675	8,258,878
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
U.S. Government and Agency Backed Securities [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,438,315
U.S. Government and Agency Backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
U.S. Government and Agency Backed Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,438,315
U.S. Government and Agency Backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Certificates of Deposit [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	7,172,170	490,603
Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	7,172,170	490,603
Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Equity Investments [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,603,014
Equity Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	169,112
Equity Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Equity Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	$ 4,433,902
US Government Corporations and Agencies Securities [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		2,397,730
US Government Corporations and Agencies Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
US Government Corporations and Agencies Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		2,397,730
US Government Corporations and Agencies Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Corporate Debt Securities [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		1,500,445
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		1,500,445
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Equity Method Investments [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		7,721,206
Equity Method Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		213,016
Equity Method Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Equity Method Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value		$ 7,508,190

SCHEDULE OF FAIR VALUE, LIABILI

SCHEDULE OF FAIR VALUE, LIABILITIES MEASURED ON RECURRING BASIS (Details)	9 Months Ended
	Sep. 30, 2023 USD ($)
Equity Method Investments [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instrument fair value, beginning	$ 7,508,190
Net unrealized gains	(3,327,347)
Foreign currency losses	(186,395)
Purchases, issuances and settlements	439,454
Equity Investments [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instrument fair value, ending	$ 4,433,902

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)		2 Months Ended	3 Months Ended					9 Months Ended
	Sep. 30, 2019	Jun. 25, 2022	Sep. 30, 2023	Sep. 30, 2023	Jul. 03, 2023	Mar. 26, 2022	Dec. 28, 2019	Sep. 30, 2023	Sep. 24, 2022
Asset impairment charges			$ 0				$ 5,200,000	$ 3,100,000
Investments							$ 0
Gain on Sale of Investments						$ 4,700,000
Payments to Acquire Equity Method Investments		$ 500,000
Payments for Royalties					$ 400,000
Inventory								292,405	$ 1,670,993
Unrealized gain on equity interest				$ 100,000				200,000
Asset Purchase Agreement [Member]
Sale of Stock, Description of Transaction	As consideration for the transaction, the Company received a 20.0% equity stake in Solos Incorporation (“Solos Inc.”). The Company’s 20.0% equity stake will be maintained until Solos Inc. has raised a total of $
Equity Method Investment, Aggregate Cost	$ 7,500,000
Investment Owned, Fair Value	600,000
Realized Investment Gains (Losses)	600,000
[custom:InvestmentOwned-0]	$ 400,000
Inventory			$ 0					$ 200,000
Equity Investment [Member]
Equity Method Investment, Ownership Percentage			2.90%	2.90%				2.90%

SCHEDULE OF ACCOUNTS RECEIVABLE

SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Accounts receivable	$ 8,143,214	$ 6,840,891
Less — allowance for credit losses	(1,025,000)	(303,000)
Total	$ 7,118,214	$ 6,537,891

SCHEDULE OF CHANGE IN ALLOWANCE

SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES (Details)	9 Months Ended
	Sep. 30, 2023 USD ($)
Receivables [Abstract]
Balance, December 31, 2022	$ 303,000
Additions	798,000
Write-offs	(76,000)
Balance, September 30, 2023	$ 1,025,000

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 5,522,913	$ 4,285,757
Work-in-process	2,527,748	1,735,454
Finished goods	1,023,831	405,189
Total	$ 9,074,492	$ 6,426,400

SCHEDULE OF NON-VESTED RESTRICT

SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Net loss per share
Non-vested restricted common stock	3,948,417	2,480,299	3,948,417	2,480,299

SCHEDULE OF NON-VESTED RESTRI_2

SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Equity [Abstract]
Number of shares, restricted stock outstanding beginning | shares	1,965,901
Weighted average grant date fair value, restricted stock outstanding beginning | $ / shares	$ 2.22
Number of shares, restricted stock granted | shares	3,296,051
Weighted average grant date fair value, restricted stock granted | $ / shares	$ 1.59
Number of shares, restricted stock forfeited | shares	(800,842)
Weighted average grant date fair value, restricted stock forfeited | $ / shares	$ 2.83
Number of shares, restricted stock vested | shares	(512,693)
Weighted average grant date fair value, restricted stock vested | $ / shares	$ 1.55
Number of shares, restricted stock outstanding ending | shares	3,948,417
Weighted average grant date fair value, restricted stock outstanding ending | $ / shares	$ 1.66

STOCKHOLDERS_ EQUITY AND STOC_3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended
	Jan. 27, 2023	Apr. 01, 2023	Jun. 25, 2022	Sep. 30, 2023	Sep. 24, 2022
Class of Warrant or Right [Line Items]
Number of registered common stock sold	17,000,000
Proceeds from Issuance of Common Stock				$ 21,335,000	$ 2,397,618
Sale of Stock, Price Per Share			$ 1.26
Stock Issued During Period, Value, New Issues		$ 21,335,000	$ 41,400,000
Restricted stock granted				3,296,051
Restricted stock granted				512,693
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount				$ 6,600,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				3 years
Successful Achievement Of Milestones [Member]
Class of Warrant or Right [Line Items]
Restricted stock granted				1,879,757	3,296,051
Restricted Stock Units (RSUs) [Member]
Class of Warrant or Right [Line Items]
Restricted stock granted				3,296,051	996,500
Time Based [Member]
Class of Warrant or Right [Line Items]
Restricted stock granted				1,416,294	3,296,051
Treasury Stock, Common [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Value, New Issues
Prefunded Warrants [Member]
Class of Warrant or Right [Line Items]
Number of registered common stock sold			100,000
Pre-funded warrants issued to purchase common stock	6,000,000
Offering price per share	$ 0.99
Proceeds from issuance of warrants	$ 21,400,000
Underwriting discounts and offering expenses	$ 1,500,000
Exercise price of warrants	$ 0.01
Proceeds from Issuance of Common Stock			$ 2,100,000
Sale of Stock, Consideration Received Per Transaction			$ 50,000,000
Prefunded Warrants [Member] | Treasury Stock, Common [Member]
Class of Warrant or Right [Line Items]
Number of registered common stock sold			200,000
Prefunded Warrants [Member] | Over-Allotment Option [Member]
Class of Warrant or Right [Line Items]
Proceeds from issuance of warrants	$ 22,900,000
Common Stock [Member]
Class of Warrant or Right [Line Items]
Number of registered common stock sold			1,500,000

SCHEDULE OF ACCRUED WARRANTY (D

SCHEDULE OF ACCRUED WARRANTY (Details)	9 Months Ended
	Sep. 30, 2023 USD ($)
Guarantees and Product Warranties [Abstract]
Balance, December 31, 2022	$ 1,966,000
Additions	676,000
Claims	(481,000)
Balance, September 30, 2023	$ 2,161,000

ACCRUED WARRANTY (Details Narra

ACCRUED WARRANTY (Details Narrative) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Revenue Benchmark [Member]
Extended product warranty description	Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months
Standard product warranty description	standard 12 to 18 month warranty
Warrant [Member]
Extended product warranty description	The Company typically warrants its products against defects for 12 to 18 months
Deferred revenue	$ 0.1

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Current income tax expense (benefit)			$ 0.1	$ 0.1
Operating loss carryforwards	$ 135.5		135.5
Operating loss carryforwards unlimited	92.9		$ 92.9
Maximum [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Current income tax expense (benefit)	$ 0.1	$ 0.1

SCHEDULE OF CONTRACT WITH CUSTO

SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Contract Assets And Liabilities
Contract assets - current	$ 5,882,340	$ 4,068,364
Change in contract assets - current	$ 1,813,976
Percentage of change in contract assets - current	45%
Contract liabilities - current	$ (668,046)	(930,500)
Change Contract liabilities - current	$ 262,454
Percentage of change in contract liabilities - current	(28.00%)
Contract liabilities - noncurrent	$ (23,431)	(6,190)
Change in contract liabilities - noncurrent	$ (17,241)
Percentage of change in contract liabilities - noncurrent	279%
Net contract assets	$ 5,190,863	$ 3,131,674
Change in net contract assets	$ 2,059,189
Percentage of change in net contract assets	66%

SCHEDULE OF SATISFACTION OF PER

SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Performance obligation percentage	24%	29%	27%	23%
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Performance obligation percentage	76%	71%	73%	77%

CONTRACT ASSETS AND LIABILITI_3

CONTRACT ASSETS AND LIABILITIES (Details Narrative) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Change in net contract assets	$ 2		$ 2
Contract with customer, liability, revenue recognized		$ 0.5	0.7	$ 3.6
Revenue, remaining performance obligation, amount	14.2		$ 14.2
Maximum [Member]
Contract with customer, liability, revenue recognized	$ 0.1

SCHEDULE OF LEASE EXPENSE (Deta

SCHEDULE OF LEASE EXPENSE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Leases
Operating lease cost	$ 216,119	$ 242,833	$ 648,545	$ 742,697

SCHEDULE OF FUTURE LEASE PAYMEN

SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE (Details)	Sep. 30, 2023 USD ($)
Leases
2023 (excluding the nine months ended September 30, 2023)	$ 234,233
2024	894,227
2025	637,893
2026	604,000
2027	604,000
Thereafter	201,333
Total future lease payments	3,175,686
Less imputed interest	(405,088)
Total	$ 2,770,598

SCHEDULE OF OPERATING LEASE PAY

SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Leases
Operating lease liabilities - current	$ 762,521	$ 786,928
Operating lease liabilities - noncurrent	2,008,077	$ 2,576,883
Total	$ 2,770,598

SCHEDULE OF SUPPLEMENTAL INFORM

SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)	9 Months Ended
	Sep. 30, 2023 USD ($)
Leases
Cash paid for amounts included in the measurement of operating lease liabilities	$ 741,757
Weighted Average Discount Rate - Operating Leases	6.06%
Weighted Average Remaining Lease Term-Operating Leases (in years)	4 years 1 month 9 days

SCHEDULE OF LONG-LIVED ASSETS B

SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	$ 4,465	$ 5,000
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	4,194	4,604
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	$ 271	$ 396

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 10,598,497	$ 11,729,379	$ 31,816,544	$ 35,216,833
Percentage of total revenue	100%	100%	100%	100%
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 9,879,000	$ 9,360,000	$ 27,788,000	$ 28,695,000
Percentage of total revenue	94%	80%	88%	82%
Other Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues		$ 4,000	$ 5,000	$ 4,000
Percentage of total revenue
Total Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 9,879,000	$ 9,364,000	$ 27,793,000	$ 28,699,000
Percentage of total revenue	94%	80%	88%	82%
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 363,000	$ 2,039,000	$ 2,956,000	$ 5,747,000
Percentage of total revenue	3%	17%	9%	16%
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 356,000	$ 326,000	$ 1,068,000	$ 771,000
Percentage of total revenue	3%	3%	3%	2%

SCHEDULE OF SEGMENT REPORTING I

SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Revenue from External Customer [Line Items]
Total Revenues	$ 10,598,497	$ 11,729,379	$ 31,816,544	$ 35,216,833
Defense [Member]
Revenue from External Customer [Line Items]
Total Revenues	4,996,000	5,851,000	16,482,000	17,695,000
Industrial [Member]
Revenue from External Customer [Line Items]
Total Revenues	310,000	1,727,000	2,118,000	4,889,000
Consumer [Member]
Revenue from External Customer [Line Items]
Total Revenues	200,000	676,000	573,000	1,182,000
Research And Development [Member]
Revenue from External Customer [Line Items]
Total Revenues	4,956,000	3,375,000	11,737,000	11,089,000
License And Royalties [Member]
Revenue from External Customer [Line Items]
Total Revenues	$ 136,000	$ 100,000	$ 907,000	$ 362,000

SCHEDULE OF TRANSACTIONS WITH R

SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Sales	$ 485,338	$ 437,825	$ 1,757,739	$ 1,219,771
Purchase	208,933		416,988
Receivables	241,632		241,632		$ 325,106
Payables	154,933		154,933
RealWear, Inc. [Member]
Related Party Transaction [Line Items]
Sales	135,918	108,725	905,564	827,746
Purchase
Receivables	135,918		135,918		171,518
Payables
HMDMd Inc [Member]
Related Party Transaction [Line Items]
Sales	349,420	329,100	852,175	392,025
Purchase
Receivables	92,752		92,752		151,340
Payables
Lightning Silicon Techonology Inc [Member]
Related Party Transaction [Line Items]
Sales
Purchase	208,933		416,988
Receivables	12,962		12,962
Payables	154,933		154,933
Solos Technology [Member]
Related Party Transaction [Line Items]
Receivables					2,248
Payables